Designing human experiences in the age of AI.
Links curated by Peter Polgar.
For a weekly newsletter of hand selected links, signup here.
Posted on 2018 April 15 by polgarp · Tagged in Healthcare
Original link: https://www.theverge.com/2018/4/11/17224984/artificial-intelligence-idxdr-fda-eye-disease-diabetic-rethinopathy
This is significant, as it’s the first autonomous device that is approved, to be used without a specialist. The FDA is usually very rigorous on device approvals, one of the results being that less and less patient harm happens because of device errors and design errors.